
Our Approach to Preclinical Excellence in Pharmaceutical
Pharmaceutical research demands precision, innovation and agility to address the complexities of modern drug development. At Galileo Research, we bring decades of expertise in delivering tailored non-clinical studies that are scientifically rigorous and operationally efficient. By leveraging our comprehensive portfolio of bioanalytical, pharmacological, and toxicological services, we ensure your therapeutic candidates advance smoothly towards first-in-human trials and beyond.
Our approach is focused on delivering practical, measurable benefits to address your most pressing challenges:
-
Real-Time Oversight for Seamless Progress
We keep you fully informed with real-time project updates, reducing the risk of delays and ensuring your studies are audit-ready at all times. -
Streamlined Study Execution for Faster Results
Our integrated workflows combine cutting-edge study designs and precise execution to accelerate data collection and regulatory submissions, helping you stay ahead of market competition. -
Actionable Insights for Clinical Success
With data-driven methodologies, we help clients de-risk development, identify red flags early, and provide robust evidence to guide clinical strategies—reducing late-stage attrition rates and protecting your investment.
At Galileo Research, we are more than a service provider; we are your strategic partner in bringing innovative therapies to patients, faster and smarter.
Comprehensive Services for Pharmaceutical Research and Regulatory Compliance
- In silico Predictions
- In vitro and in vivo Pharmacology
-
In vitro and in vivo ADME
- Biological Barriers Permeability
- Stability
- Binding
- CYP450
- Pharmacokinetic interactions -
In vitro and in vivo Toxicology
- Single and Repeated Systemic Toxicity with toxicokinetics
- Genotoxicity
- Reproductive Toxicity
- Local Tolerance
- Cytotoxicity
- Immunotoxicity -
Molecular Analysis
- mechanisms of action
- target identification
- protein expression
- gene expression - Sensitization (Mouse Local Lymph Node Assay)
- Regulatory toxicology (GLP compliant)
- Management and Planning of the non-clinical phase
-
Regulatory Support
- CTD
- Expert Report
- PDE